Patent details

EP2111863 Title: Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension

Basic Information

Publication number:
EP2111863
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP090072323
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
French Title of Invention:
Combinaison du fasudil et bosentan pour le traitement de l'hypertension artérielle pulmonaire
German Title of Invention:
Fasudil in Kombination mit Bosentan zur Behandlung von pulmonaler arterieller Hypertonie
SPC Number:

Dates

Filing date:
25/10/2006
Grant date:
28/03/2012
EP Publication Date:
28/03/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/10/2009
EP B1 Publication Date:
28/03/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/10/2012
Expiration date:
25/10/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2006
 
 

Name:
Asahi Kasei Pharma Corporation
Address:
1-105 Kanda Jinbocho Chiyoda-ku, Tokyo 101-8101, Japan (JP)

Inventor

Name:
Fong Benson
Address:
United States (US)

Priority

Priority Number:
730273 P
Priority Date:
26/10/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/551;
Filing date Document type Number of pages